1. Home
  2. CXM vs RAPP Comparison

CXM vs RAPP Comparison

Compare CXM & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sprinklr Inc.

CXM

Sprinklr Inc.

HOLD

Current Price

$5.44

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$40.45

Market Cap

1.3B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CXM
RAPP
Founded
2009
2022
Country
United States
United States
Employees
3258
N/A
Industry
Computer Software: Prepackaged Software
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
2021
2024

Fundamental Metrics

Financial Performance
Metric
CXM
RAPP
Price
$5.44
$40.45
Analyst Decision
Hold
Strong Buy
Analyst Count
8
6
Target Price
$8.31
$48.50
AVG Volume (30 Days)
3.0M
255.4K
Earning Date
06-03-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
24.34
EPS
0.09
N/A
Revenue
$857,200,000.00
N/A
Revenue This Year
$2.52
N/A
Revenue Next Year
$4.94
N/A
P/E Ratio
$62.61
N/A
Revenue Growth
7.64
N/A
52 Week Low
$5.12
$7.73
52 Week High
$9.40
$42.27

Technical Indicators

Market Signals
Indicator
CXM
RAPP
Relative Strength Index (RSI) 40.68 80.77
Support Level $5.19 $25.48
Resistance Level $6.16 $42.27
Average True Range (ATR) 0.23 2.11
MACD -0.04 0.84
Stochastic Oscillator 26.18 95.61

Price Performance

Historical Comparison
CXM
RAPP

About CXM Sprinklr Inc.

Sprinklr Inc is engaged in enabling customer-facing teams, from Customer Service to Marketing, to collaborate across internal silos, communicate across digital channels, and leverage AI to deliver customer experiences at scale, all on one unified AI-based platform. It focuses on empowering companies to deliver next-generation, unified engagement journeys that reimagine the customer's experience. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights, and Sprinklr Marketing. The company operates in the Americas, EMEA, and other countries. It derives maximum revenue from the Americas.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: